W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > May 2008

RE: KB note

From: Elizabeth Wu <ewu@alzforum.org>
Date: Mon, 26 May 2008 08:26:33 -0400
To: <kc28@email.med.yale.edu>, "'Tim Clark'" <twclark@nmr.mgh.harvard.edu>
Cc: "'M. Scott Marshall'" <marshall@science.uva.nl>, <public-semweb-lifesci@w3.org>
Message-ID: <E1K0bn9-0000gn-4z@maggie.w3.org>

Hi Kei,

There is an entry in the Drugs in Clinical Trials section of Alzforum on
Huperzine A http://www.alzforum.org/drg/drc/detail.asp?id=53. The drug is
currently in Phase IV clinical trial in China and phase II in the US.  Its
proposed actions are linked to many of the AD hypotheses, and I would think
that if there are sources on research on herbs that could provide more
insight, it would be of interest to the community.

Best,

Elizabeth

Elizabeth Wu
Alzheimer Research Forum
 

-----Original Message-----
From: public-semweb-lifesci-request@w3.org
[mailto:public-semweb-lifesci-request@w3.org] On Behalf Of
kc28@email.med.yale.edu
Sent: Sunday, May 25, 2008 10:41 PM
To: Tim Clark
Cc: M. Scott Marshall; public-semweb-lifesci@w3.org
Subject: Re: KB note


Hi Tim et al.,

I think it would be great if more details about SWAN can be added. The HCLS
ecosystem consists of scientists, patients, doctors, government agencies,
publishers, etc. Creating/maintaining a balance in this digital age across
national boundaries is challenging/interesting.

Speaking of national boundaries, I wonder if alternative medicine (e.g.,
herbal
medicine) would also be of interest to this community. For example,
Huperzine
is a drug derived from the herb Huperzia serrata. I also wonder if there are
hypotheses regarding the study of herbs in the possible treatment of
neurological diseases.

Thanks,

-Kei


Quoting Tim Clark <twclark@nmr.mgh.harvard.edu>:

>
> Hi Scott,
>
> Your KB note lists no details about SWAN - we would like to see them
> included.  I'll forward something to you in a separate email later
> today.
>
> Best
>
> Tim
>
> Tim Clark
> Director of Informatics, MassGeneral Institute for Neurodegenerative
> Disease
> Instructor in Neurology, Harvard Medical School
> 617-947-7098 (mobile)
>
> On May 23, 2008, at 6:59 PM, M. Scott Marshall wrote:
>
> >
> > The KB note is ready for a last round of feedback and corrections.
> > We have until the end of the month to publish so please be speedy
> > with feedback. You can view the Editor's working draft at:
> http://www.w3.org/2001/sw/hcls/notes/kb/
> >
> > Thanks,
> > Scott
> >
> > --
> > M. Scott Marshall
> > tel. +31 (0) 20 525 7522
> > http://staff.science.uva.nl/~marshall
> > http://adaptivedisclosure.org
> >
> >
> >
> >
>
>
>
>
Received on Monday, 26 May 2008 12:27:16 UTC

This archive was generated by hypermail 2.3.1 : Wednesday, 7 January 2015 14:52:36 UTC